Ensysce Biosciences, Inc. - Common Stock, par value $0.0001 per share (ENSC)

Q: What does CUSIP 293602504 represent in this 13F holders report?

CUSIP 293602504 is the security identifier for ENSC - Ensysce Biosciences, Inc. - Common Stock, par value $0.0001 per share used to aggregate holder disclosures.

Q: How many institutions held ENSC - Ensysce Biosciences, Inc. - Common Stock, par value $0.0001 per share in Q3 2025?

17 institutional investors reported ENSC - Ensysce Biosciences, Inc. - Common Stock, par value $0.0001 per share for Q3 2025. Use the holders table for investor-level position and value details.

CUSIP: 293602504

Q3 2025 13F Holders as of 30 Sep 2025

Type / Class: Equity / Common Stock, par value $0.0001 per share
Shares outstanding: 2,371,778
Total 13F shares: 351,699
Share change: +172,546
Total reported value: $833,709
Price per share: $2.37
Number of holders: 17
Value change: +$409,291
Number of buys: 11
Number of sells: 4

Quarterly Holders Quick Answers

What is CUSIP 293602504?
CUSIP 293602504 identifies ENSC - Ensysce Biosciences, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q4 2025
Previous quarter: Q2 2025

Recent filing periods for CUSIP 293602504:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024

Top shareholders of ENSC - Ensysce Biosciences, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
A. Lorne Weil	3/4/5	10%+ Owner	— class O/S missing	1,868,005	$1,868,005	—	30 Jun 2021	3/4/5
Daniel B. Silvers	3/4/5	10%+ Owner	— class O/S missing	1,754,497	$1,754,497	—	30 Jun 2021	3/4/5
William H. Chang	3/4/5	Director, 10%+ Owner	— mixed-class rows	2,630,640 mixed-class rows	$1,267,451	—	23 Jun 2022	3/4/5
Bob G. Gower	3/4/5	Director	— class O/S missing	1,222,682	$597,036	—	02 Mar 2023	3/4/5
PERCEPTIVE ADVISORS LLC	13D/G 13F	Company	3.7%	86,666	$264,331	$0	31 Mar 2025	13D/G 13F
Anson Funds Management LP	13D/G	—	2.1%	411,681	$209,957	$0	31 Dec 2024	13D/G
Lynn Kirkpatrick	3/4/5	Chief Executive Officer, Director	— mixed-class rows	2,898,790 mixed-class rows	$186,458	—	25 May 2022	3/4/5
Adage Capital Management, L.P.	13D/G	—	3.2%	74,711	$167,353	$0	30 Jun 2025	13D/G
ADAGE CAPITAL PARTNERS GP, L.L.C.	13F	Company	3.1%	74,711	$166,606	—	30 Jun 2025	13F
Eric Carrera	3/4/5	Former officer	— class O/S missing	30,000	$30,000	—	30 Jun 2021	3/4/5
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.43%	10,161	$22,658	—	30 Jun 2025	13F
George Peng	3/4/5	Former officer	— class O/S missing	15,000	$15,000	—	30 Jun 2021	3/4/5
FNY Investment Advisers, LLC	13F	Company	0.13%	3,000	$6,000	—	30 Jun 2025	13F
SBI Securities Co., Ltd.	13F	Company	0.1%	2,336	$5,209	—	30 Jun 2025	13F
Tower Research Capital LLC (TRC)	13F	Company	0.06%	1,369	$3,053	—	30 Jun 2025	13F
MORGAN STANLEY	13F	Company	0.02%	378	$843	—	30 Jun 2025	13F
UBS Group AG	13F	Company	0.01%	354	$789	—	30 Jun 2025	13F
RAYMOND JAMES FINANCIAL INC	13F	Company	0%	94	$210	—	30 Jun 2025	13F
BlackRock, Inc.	13F	Company	0%	65	$145	—	30 Jun 2025	13F
BANK OF AMERICA CORP /DE/	13F	Company	0%	19	$42	—	30 Jun 2025	13F
Richard Chester Wright	3/4/5	Chief Business Officer	— class O/S missing	987,750	—	—	30 Jun 2021	3/4/5
Linda Pestano	3/4/5	Chief Development Officer	— class O/S missing	200,000	—	—	04 Feb 2022	3/4/5
Andrew Benton	3/4/5	Director	— class O/S missing	100,850	—	—	23 Jun 2022	3/4/5
Steven Robert Martin	3/4/5	Director	— class O/S missing	100,850	—	—	23 Jun 2022	3/4/5
David Carl Humphrey	3/4/5	Chief Financial Officer	— class O/S missing	80,000	—	—	17 Feb 2022	3/4/5
William K. Schmidt	3/4/5	Chief Medical Officer	— class O/S missing	69,142	—	—	30 Jun 2021	3/4/5
Kevin Geoffrey Birkett	3/4/5	Chief Commercial Officer	— class O/S missing	50,000	—	—	17 Feb 2022	3/4/5
Adam Levin	3/4/5	Director	— class O/S missing	35,000	—	—	23 Jun 2022	3/4/5
Curtis Rosebraugh	3/4/5	Director	— class O/S missing	35,000	—	—	23 Jun 2022	3/4/5
Lee M. Rauch	3/4/5	Director	— class O/S missing	35,000	—	—	23 Jun 2022	3/4/5

Institutional Holders of Ensysce Biosciences, Inc. - Common Stock, par value $0.0001 per share (ENSC) as of Q3 2025

As of 30 Sep 2025, Ensysce Biosciences, Inc. - Common Stock, par value $0.0001 per share (ENSC) was held by 17 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 351,699 shares. The largest 10 holders included PERCEPTIVE ADVISORS LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., DRW Securities, LLC, VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, CITADEL ADVISORS LLC, Virtu Financial LLC, GEODE CAPITAL MANAGEMENT, LLC, XTX Topco Ltd, and TRU INDEPENDENCE ASSET MANAGEMENT 2, LLC. This page lists 17 institutional shareholders reporting positions in this security for the Q3 2025 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q3 2025 vs Q2 2025 Across Filers

Q2 2025 holders

Q3 2025 holders

Holder diff

Investor	Q2 2025 Shares	Q3 2025 Shares	Share Diff	Share Chg %	Q2 2025 Value $	Q3 2025 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.